Mucoepidermoid carcinoma of the head and neck: Clinical analysis of 43 patients

Japanese Journal of Clinical Oncology

Volumn 38, Issue 6, 2008, Pages 414-418

  Ozawa, Hiroyuki ^a,b   Tomita, Toshiki ^a   Sakamoto, Koji ^a   Tagawa, Takamasa ^a   Fujii, Ryoichi ^a   Kanzaki, Sho ^a   Ogawa, Kaoru ^a   Kameyama, Kaori ^a   Fujii, Masato ^c  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIZUOKA RED CROSS HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Head and neck cancer; Mucoepidermoid carcinoma; Prognosis; Salivary gland

Indexed keywords

CISPLATIN;

ADENOSQUAMOUS CARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; DISEASE FREE SURVIVAL; FEMALE; GLOSSECTOMY; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HUMAN; LYMPH NODE DISSECTION; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PAROTIDECTOMY; PROGNOSIS; SURVIVAL RATE; ADJUVANT THERAPY; ANALYSIS OF VARIANCE; CANCER STAGING; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SALIVARY GLAND TUMOR; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, MUCOEPIDERMOID; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; SEX FACTORS; TREATMENT OUTCOME;

EID: 46349095147     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn045     Document Type: Article

References (20)

1. Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer 1992;69:2021-30.
2. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: Clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998;82:1217-24.
3. Wittenkind C, Greene FL, Hutter RVP, Klimplinger M, Sobin LH. TNM Atlas. 5th edn. Berlin Heidelberg New York: Springer 2004,5-65.
4. Goode RK, El-Naggar AK. Mucoepidermoid Carcinoma. WHO Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press 2005,219-20.
5. Guzzo M, Andreola S, Sirizzotti G, Cantu G. Mucoepidermoid carcinoma of the salivary glands: Clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol. 2002;9:688-95.
6. Plambeck K, Friedrich RE, Hellner D, Donath K, Schmelzie R. Mucoepidermoid carcinoma of the salivary glands, Clinical data and follow-up of 52 cases. J Cancer Res Clin Oncol 1996,122:177-80.
7. Boahene DK, Olsen KD, Lewis JE, Pinhciro AD, Pankratz VS, Bagniewski SM. Mucoepidermoid carcinoma of the parotid gland: The Mayo clinic experience. Arch Otolaryngol Head Neck Surg 2004; 130:849-56.
8. Hicks MJ, el-Naggar AK, Flaitz CM, Luna MA, Batsakis JG. Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: A clinicopathologic and flow cytometric investigation. Head Neck 1995;17:89-95.
9. Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer 1999;85:2057-67.
10. Luukkaa H, Klemi P, Leivo I, Koivunen P, Laranne J, Makitie A, et al. Salivary gland cancer in Finland 1991-96: An evaluation of 237 cases. Acta Otolaryngol 2005; 125:207-14.
11. Carrillo JF, Vazquez R, Ramirez-Ortega MC, Cano A, Ochoa-Carrillo FJ, Onate-Ocana LF. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer 2007; 109:2043-51.
12. Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, et al. Mucoepidermoid carcinoma: A clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001;25:835-45.
13. Rapidis AD, Givalos N, Gakiopoulou H, Stavrianos SD, Faratzis G, Lagogiannis GA, et al. Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients. Oral Oncol 2007;43:130-6.
14. Spiro RH, Huvos AG, Berk R, Strong EW. Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg 1978;136:461-8.
15. Evans HL. Mucoepidermoid carcinoma of salivary glands: A study of 69 cases with special attention to Histologic grading. Am J Clin Pasthol 1984;81:696-701.
16. Kumar N, Kapila K, Verma K. Fine needle aspiration cytology of mucoepidermoid carcinoma. A diagnostic problem. Acta Cytol 1991;35:357-9.
17. Healey WV, Przin KH, Smith L. Mucoepidermoid carcinoma of salivary gland origin, Classification, clinical-pathologic correlation, and results of treatment. Cancer 1970;26:368-88.
18. Hosokawa Y, Shirato H, Kagei K, Hashimoto S, Nishioka T, Tei K, et al. Role of radiotherapy for mucoepidermoid carcinoma of salivary glan Oral Oncol 1999;35:105-11.
19. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB. Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer 2005;103:2544-50.
20. Laurie SA, Licitra L. Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol 2006;24:2673-8.